[Treatment results in osteogenic sarcoma in children and adolescents with the use of karminomycin].
Carminomycin, a new antibiotic made in the USSR, was used in the treatment of 21 patients aged 5 to 15 years with extended osteogenic sarcoma. As a result of the treatment the number of the patients with lifetime prolonged for 1-2 years increased from 7.6 to 46 per cent. It was shown that the drug might be used for the prophylaxis of the localized forms of the disease in children.
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary; D002360:Carubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003630:Daunorubicin / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008207:Lymphatic Metastasis; D008558:Melphalan / Q000008:administration & dosage; D012516:Osteosarcoma / Q000188:drug therapy* / Q000532:radiotherapy; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D002360:Carubicin; D008558:Melphalan; D003630:Daunorubicin
Rezul'taty lecheniia osteogennoĭ sarkomy u deteĭ i podrostkov pri ispol'zovanii karminomitsina.